PET-CT detects response to treatment with ipilimumab and nivolumab in malignant mesothelioma far better than CT
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany
In: Oncology Research and Treatment, Vol. 46 (2023), No. Supplement 5: DGHO Abstracts, pp. 226 - 227
2023poster abstract in journalOA Bronze
MedicineFaculty of Medicine » Essen University Hospital » Kliniken Essen-MitteFaculty of Medicine » Essen University Hospital » Clinic for Internal Medicine (Tumor Research)Faculty of Medicine » Essen University Hospital » Ruhrlandklinik Essen – UniversitätsklinikFaculty of Medicine » Essen University Hospital » Clinic for Nuclear Medicine
Title in English:
PET-CT detects response to treatment with ipilimumab and nivolumab in malignant mesothelioma far better than CT
Conference
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany
Author:
Christoph, DanielUDE
- GND
- 1131942183
- GND
- 55578
- LSF ID
- 55578
- ORCID
-
0000-0002-3151-6427
- Other
- connected with university
- LSF ID
- 56061
- Other
- connected with university
Year of publication:
2023
Open Access?:
OA Bronze
Web of Science ID
Note:
Poster-Abstract
Language of text:
English
Appears in
Title in English (abbreviated):
Oncol. Res. Treat.
Place of publication:
Basel
Publisher:
Karger
in:
Vol. 46 (2023), No. Supplement 5: DGHO Abstracts, pp. 226 - 227
ISSN
ISSN
ZDB ID
Note:
ab 37.2014
Type of resource:
Text
Type of resource:
Text